These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33652672)

  • 21. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and 5-HT1A/5-HT2A receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J; Tatarczyńska E; Nikiforuk A; Charakchieva-Minol S; Duszyńska B
    Pharmacol Rep; 2006; 58(1):107-14. PubMed ID: 16531637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
    Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Pol J Pharmacol; 2004; 56(6):743-54. PubMed ID: 15662087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-5-HT/D
    Żmudzki P; Satała G; Chłoń-Rzepa G; Bojarski AJ; Kazek G; Siwek A; Gryboś A; Głuch-Lutwin M; Wesołowska A; Pawłowski M
    Arch Pharm (Weinheim); 2016 Oct; 349(10):774-784. PubMed ID: 27510801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo.
    Valhondo M; Marco I; Martín-Fontecha M; Vázquez-Villa H; Ramos JA; Berkels R; Lauterbach T; Benhamú B; López-Rodríguez ML
    J Med Chem; 2013 Oct; 56(20):7851-61. PubMed ID: 24050112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile.
    Sun H; Zhu L; Yang H; Qian W; Guo L; Zhou S; Gao B; Li Z; Zhou Y; Jiang H; Chen K; Zhen X; Liu H
    Bioorg Med Chem; 2013 Feb; 21(4):856-68. PubMed ID: 23332346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
    J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2.
    Herold F; Izbicki Ł; Chodkowski A; Dawidowski M; Król M; Kleps J; Turło J; Wolska I; Nowak G; Stachowicz K; Dybała M; Siwek A; Nowak M; Pieniazek E; Jarończyk M; Sylte I; Mazurek AP
    Eur J Med Chem; 2009 Nov; 44(11):4702-15. PubMed ID: 19665823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
    Maeda K; Sugino H; Akazawa H; Amada N; Shimada J; Futamura T; Yamashita H; Ito N; McQuade RD; Mørk A; Pehrson AL; Hentzer M; Nielsen V; Bundgaard C; Arnt J; Stensbøl TB; Kikuchi T
    J Pharmacol Exp Ther; 2014 Sep; 350(3):589-604. PubMed ID: 24947465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT
    Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Leśniak A; Sacharczuk M; Trzaskowski B
    Bioorg Med Chem; 2018 Jan; 26(2):527-535. PubMed ID: 29269256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CoMFA methodology in structure-activity analysis of hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives based on affinity towards 5-HT1A, 5-HT2A and alpha1-adrenergic receptors.
    Maciejewska D; Zołek T; Herold F
    J Mol Graph Model; 2006 Nov; 25(3):353-62. PubMed ID: 16542863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-5-HT receptor affinity relationship in a new group of 7-arylpiperazynylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione.
    Żmudzki P; Chłoń-Rzepa G; Bojarski AJ; Zygmunt M; Kazek G; Mordyl B; Pawłowski M
    Arch Pharm (Weinheim); 2015 Apr; 348(4):229-41. PubMed ID: 25773578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors.
    Herold F; Kleps J; Wolska I; Nowak G
    Farmaco; 2002 Dec; 57(12):959-71. PubMed ID: 12564469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
    Boksa J; Mokrosz MJ; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Wesołowska A; Misztal S
    Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ; Kowalski P; Kowalska T; Majka Z; Duszyńska B; Charakchieva-Minol S; Szaro A; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New 5-HT
    Fiorino F; Magli E; Kędzierska E; Ciano A; Corvino A; Severino B; Perissutti E; Frecentese F; Di Vaio P; Saccone I; Izzo AA; Capasso R; Massarelli P; Rossi I; Orzelska-Gòrka J; Kotlińska JH; Santagada V; Caliendo G
    Bioorg Med Chem; 2017 Oct; 25(20):5820-5837. PubMed ID: 28943244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.
    Asagarasu A; Matsui T; Hayashi H; Tamaoki S; Yamauchi Y; Minato K; Sato M
    J Med Chem; 2010 Nov; 53(21):7549-63. PubMed ID: 20931963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of a new series of aryl/heteroarylpiperazinyl derivatives of 8-acetyl-7-hydroxy-4-methylcoumarin with low nanomolar 5-HT
    Ostrowska K; Młodzikowska K; Głuch-Lutwin M; Gryboś A; Siwek A
    Eur J Med Chem; 2017 Sep; 137():108-116. PubMed ID: 28575721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
    Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
    Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.